Any drug-discovery company would be pleased to have discovered 16 drug candidates in the last five years and have progressed six of these into early clinical trials. And any academic research institution would be thrilled to lead the world in finding cancer genes. The Institute of Cancer Research (ICR) in the UK can claim both of these achievements. These successes are just a sample of the ICR's accomplishments over its 100-year history, which also include linking smoking to cancer-causing DNA damage and developing many successful cancer-fighting drugs including melphalan, carboplatin and abtraterone.
展开▼
